The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Dr. Karen Torrejon Appointed As the New Chief Executive Officer of Humonix Biosciences
PRIVATEMay 02, 2024•about 2 years ago
Position
Chief Executive Officer
Company
Humonix Biosciences
Karen Torrejon
AlbanyBiotechnologyPharmaceutical
Description
Humonix Biosciences, Inc. announced the appointment of Dr. Karen Torrejon as the new Chief Executive Officer, replacing Kimberly Southern
Company Information
Company
Humonix Biosciences
Location
Albany, Oregon, United States
About
Humonix Biosciences is a specialty pharma research company that uses an innovative human tissue engineering platform technology to reduce the cost of drug development.
Humonix collaborates with industry and academic partners to help screen for and identify lead candidates, elucidate their MOA and validate their efficacy.
Humonix's 3D tissue technology can reduce the risk of clinical trial failure while saving time, labor and development costs. Early identification and validation of effective compounds or biologics allows our partners to confidently enter clinical trials.
AlbanyBiotechnologyPharmaceutical